These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 19336745)
1. Quantitative risk stratification in Markov chains with limiting conditional distributions. Chan DC; Pollett PK; Weinstein MC Med Decis Making; 2009; 29(4):532-40. PubMed ID: 19336745 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657 [TBL] [Abstract][Full Text] [Related]
3. Chronic disease projections in heterogeneous ageing populations: approximating multi-state models of joint distributions by modelling marginal distributions. Hoogenveen RT; van Baal PH; Boshuizen HC Math Med Biol; 2010 Mar; 27(1):1-19. PubMed ID: 19516046 [TBL] [Abstract][Full Text] [Related]
4. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453 [TBL] [Abstract][Full Text] [Related]
5. Optimizing the start time of statin therapy for patients with diabetes. Denton BT; Kurt M; Shah ND; Bryant SC; Smith SA Med Decis Making; 2009; 29(3):351-67. PubMed ID: 19429836 [TBL] [Abstract][Full Text] [Related]
12. Estimating the ratios of the stationary distribution values for Markov chains modeling evolutionary algorithms. Mitavskiy B; Cannings C Evol Comput; 2009; 17(3):343-77. PubMed ID: 19708772 [TBL] [Abstract][Full Text] [Related]
14. A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness. Cole BF; Bonetti M; Zaslavsky AM; Gelber RD Stat Med; 2005 Aug; 24(15):2317-34. PubMed ID: 15977292 [TBL] [Abstract][Full Text] [Related]
15. A cost--utility analysis of treatment options for inguinal hernia in 1,513,008 adult patients. Stylopoulos N; Gazelle GS; Rattner DW Surg Endosc; 2003 Feb; 17(2):180-9. PubMed ID: 12415334 [TBL] [Abstract][Full Text] [Related]
16. Optimal drug pricing, limited use conditions and stratified net benefits for Markov models of disease progression. Zaric GS Health Econ; 2008 Nov; 17(11):1277-94. PubMed ID: 18186544 [TBL] [Abstract][Full Text] [Related]
17. Pertussis in adolescents and adults: should we vaccinate? Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [TBL] [Abstract][Full Text] [Related]
18. Is antibiotic prophylaxis for bacterial endocarditis cost-effective? Agha Z; Lofgren RP; VanRuiswyk JV Med Decis Making; 2005; 25(3):308-20. PubMed ID: 15951458 [TBL] [Abstract][Full Text] [Related]
19. Modeling animals' behavioral response by Markov chain models for capture-recapture experiments. Yang HC; Chao A Biometrics; 2005 Dec; 61(4):1010-7. PubMed ID: 16401274 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. DiSantostefano RL; Biddle AK; Lavelle JP BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]